# Multi-State Structural Genomics Enables Large-Scale, Mechanistic, and Context-Specific Classification of ABCC6 Genetic Variants Implicated in Calcification Diseases

**Authors:** Jessica B. Wagenknecht, Neshatul Haque, Salomao D. Jorge, Brian D. Ratnasinghe, Raul Urrutia, William A. Gahl, Shira G. Ziegler, Michael T. Zimmermann

PMC · DOI: 10.3390/ijms27041832 · International Journal of Molecular Sciences · 2026-02-14

## TL;DR

This paper uses 3D protein modeling to better understand how genetic changes in ABCC6 cause calcification diseases, helping classify uncertain variants.

## Contribution

The study introduces a novel computational structural genomics approach to classify ABCC6 variants using 3D models and mechanistic ontology.

## Key findings

- Two 3D hotspots and six key functions of ABCC6 were identified that are impacted by genetic variants.
- Structure-based evidence reclassified 33 variants as Likely Pathogenic and explained pathogenicity for 41% of VUS.
- The approach improves diagnosis and highlights the potential of computational methods in variant classification.

## Abstract

Genetic variation in ATP Binding Cassette Subfamily C Member 6 (ABCC6) can cause both pseudoxanthoma elasticum (PXE) and generalized arterial calcification of infancy (GACI). There are 930 distinct missense variants in ABCC6 reported, 87% of which are of uncertain clinical significance (VUS). New approaches are needed to mechanistically interpret and classify these VUS. We developed 3D protein models of ABCC6 in three functionally relevant conformations to calculate the structural effects of variants. We also used three-dimensional (3D) hotspot detection and developed a mechanistic ontology for critical structure-based functions of ABCC6, enabling us to categorize genomic variants. We identified two 3D hotspots and six specific functions of ABCC6 which variants impact. From this, we propose a mechanism for pathogenicity for 41% of VUS according to their impacted function. We propose that 33 of these variants could be reclassified as Likely Pathogenic with the addition of these structure-based evidence. The mechanistic information we present will guide future research to better address calcification disorders and understand genetic variants. This work emphasizes the benefits of thorough, holistic, and protein-based approaches to genetic interpretation. Further, our VUS reclassification approach will improve the diagnosis of ABCC6-driven diseases, shortening diagnostic odysseys. We believe that computational structural genomics approaches will soon take prominence in genomics data interpretation and variant classification.

## Linked entities

- **Genes:** ABCC6 (ATP binding cassette subfamily C member 6) [NCBI Gene 368]
- **Diseases:** pseudoxanthoma elasticum (MONDO:0009925), generalized arterial calcification of infancy (MONDO:0018870)

## Full-text entities

- **Genes:** PPP4C (protein phosphatase 4 catalytic subunit) [NCBI Gene 5531] {aka PP-X, PP4, PP4C, PPH3, PPP4, PPX}, ABCC1 (ATP binding cassette subfamily C member 1) [NCBI Gene 281588], ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) [NCBI Gene 4363] {aka ABC29, ABCC, DFNA77, GS-X, MRP, MRP1}, TMEM11 (transmembrane protein 11) [NCBI Gene 8834] {aka C17orf35, PM1, PMI}, YCF1 (ATP-binding cassette glutathione S-conjugate transporter YCF1) [NCBI Gene 851713], ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, ABCC6 (ATP binding cassette subfamily C member 6) [NCBI Gene 368] {aka ABC34, ARA, EST349056, GACI2, MLP1, MOAT-E}, ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase 1) [NCBI Gene 5167] {aka ARHR2, COLED, M6S1, NPP1, NPPS, PC-1}, ABCC6 (ATP binding cassette subfamily C member 6) [NCBI Gene 100337270]
- **Diseases:** injury to (MESH:D014947), recessive disease (MESH:D004194), Calcification Diseases (MESH:D002114), PXE (MESH:D011561), Arterial Calcification of Infancy (MESH:C537440), arterial calcification (MESH:D061205), VUS (MESH:D065309), angioid streaks (MESH:D000793), FH (OMIM:143890)
- **Chemicals:** phosphate (MESH:D010710), nucleotide (MESH:D009711), glycine (MESH:D005998), Mg+2 (-), glutamine (MESH:D005973), ATP (MESH:D000255), lipid (MESH:D008055)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Bos taurus (bovine, species) [taxon 9913]
- **Mutations:** A1303T, G1042S, R1339L, E521D, G663S, T1130M, V810M, S317R, G12E, G1311E, arginine is replaced with glutamine, Arg1138, R600L, G1263R, P21S, R1339S, R1114C, F1493L, G663R, L522P, R807G, Q1406H, G755R, G1302R, P1483Q, L1063P, L753P, glycine with arginine, V1404M, G1296D, I1424T, Glu778 to Asp, R1235G, G1481S, G1299R, P1346S, R1314W, A23T, K502M, E18D, E699G, G1501C, S754C, A766V, R1459C, R487W, A1318T, T811A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940408/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940408/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940408/full.md

---
Source: https://tomesphere.com/paper/PMC12940408